Leen Kawas - The Microbiome of Babies

Angel Scale Biotech: Learn More   Leen Kawas PhD, managing general partner at Propel Bio Partners, invests in life science companies such as Persephone Biosciences and Inherent Bio that promise immediate benefits for humanity. An uplifting chat with a dynamic VC and founder.   Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish and Richardson.   Highlights: Sal Daher Introduces Leen Kawas What Propel Bio Partners Does Persephone Biosciences "... It's a pipeline for probiotics. They're starting with infant probiotics..." "... is anybody else working in the space of microbiome for babies? I haven't seen this..." Inherent Bio "... That's what Inherent is working on. They have identified an epigenetic signature that has the ability to better predict pregnancy outcome with men..." "...What is the profile of the kind of company that you find attractive in public markets now...?" Advice to the Audience Leen Kawas' Immigrant Story "... I want to tell entrepreneurs that are out there, no is typically not no. Just keep that in mind..." "... I just want to tell the entrepreneurs out there, you tell your own story, you work on your mission, you define your why. Keep going and you'll be successful..." Topics: building wealth, management, raising money